STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome
Science Advances · 2025
DOI: 10.1126/sciadv.adw2464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Virginia Andreani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Ger…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Job Syndrome, Haploinsufficiency. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The autosomal dominant hyper-IgE syndrome (AD-HIES) is a primary immunodeficiency, which originates from heterozygous missense mutations in the signal transducer and activator of transcription 3 ( STAT3 ) gene. It is accepted that most STAT3 variants causing AD-HIES are dominant negative. Whether haploinsufficient mutations cause a phenotype in humans is still debated. We report on a family with a heterozygous STAT3 nonsense mutation that led to rapid decay of the mutant mRNA and protein, leading to haploinsufficiency. To explore STAT3 heterozygosity, we created a Stat3 haploinsufficient ( Stat3 +/− ) mouse model in which we found that Stat3 +/− mice had increased IgE serum levels, reduced T H 17 cell differentiation, and were susceptible to a cutaneous Staphylococcus aureus infection. Together, our findings provide mechanistic evidence for the impact of haploinsufficiency in STAT3 with residual protein expression as an important cause for immune deficiency. The implications extend to the diagnosis of immunodeficiency disorders and to the design of gene therapy in situations where gene dosage matters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- TranslaTUM-Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany.
- Institute of Clinical Chemistry and Pathobiochemistry, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
- German Center for Infection Research (DZIF), partner site Munich, Munich, Germany.
- Institute for Infection Prevention and Control, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ORCID-Profile: Virginia Andreani, Aaron James Forde, Manfred Fliegauf, Nils Ott, Shiva Saghafi, Larsen Vornholz, Sophie E Isay, Jürgen Ruland, Philipp Henneke, Bodo Grimbacher
Zitieren
APA
Andreani, V., Forde, A. J., Fliegauf, M., Bressan, G., Noé, V., Ott, N., Saghafi, S., Vornholz, L., Isay, S. E., Ruland, J., Henneke, P., & Grimbacher, B. (2025). STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome. Science Advances. https://doi.org/10.1126/sciadv.adw2464
Vancouver
Andreani V, Forde AJ, Fliegauf M, Bressan G, Noé V, Ott N, et al. STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome. Science Advances. 2025. doi:10.1126/sciadv.adw2464
BibTeX
@article{Andreani2025,
author = {Andreani, Virginia and Forde, Aaron James and Fliegauf, Manfred and Bressan, Giulia and Noé, Vera and Ott, Nils and Saghafi, Shiva and Vornholz, Larsen and Isay, Sophie E and Ruland, Jürgen and Henneke, Philipp and Grimbacher, Bodo},
title = {STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adw2464}
}
EUVIMED